Literature DB >> 17720805

Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes.

Monica Dentice1, Cristina Luongo, Stephen Huang, Raffaele Ambrosio, Antonia Elefante, Delphine Mirebeau-Prunier, Ann Marie Zavacki, Gianfranco Fenzi, Marina Grachtchouk, Mark Hutchin, Andrzej A Dlugosz, Antonio C Bianco, Caterina Missero, P Reed Larsen, Domenico Salvatore.   

Abstract

The Sonic hedgehog (Shh) pathway plays a critical role in hair follicle physiology and is constitutively active in basal cell carcinomas (BCCs), the most common human malignancy. Type 3 iodothyronine deiodinase (D3), the thyroid hormone-inactivating enzyme, is frequently expressed in proliferating and neoplastic cells, but its role in this context is unknown. Here we show that Shh, through Gli2, directly induces D3 in proliferating keratinocytes and in mouse and human BCCs. We demonstrate that Gli-induced D3 reduces intracellular active thyroid hormone, thus resulting in increased cyclin D1 and keratinocyte proliferation. D3 knockdown caused a 5-fold reduction in the growth of BCC xenografts in nude mice. Shh-induced thyroid hormone degradation via D3 synergizes with the Shh-mediated reduction of the type 2 deiodinase, the thyroxine-activating enzyme, and both effects are reversed by cAMP. This previously unrecognized functional cross-talk between Shh/Gli2 and thyroid hormone in keratinocytes is a pathway by which Shh produces its proliferative effects and offers a potential therapeutic approach to BCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720805      PMCID: PMC1964817          DOI: 10.1073/pnas.0706754104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase.

Authors:  N Marsh-Armstrong; H Huang; B F Remo; T T Liu; D D Brown
Journal:  Neuron       Date:  1999-12       Impact factor: 17.173

Review 2.  The Hedgehog and Wnt signalling pathways in cancer.

Authors:  J Taipale; P A Beachy
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  Type 2 iodothyronine deiodinase expression in the cochlea before the onset of hearing.

Authors:  A Campos-Barros; L L Amma; J S Faris; R Shailam; M W Kelley; D Forrest
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 4.  Developmental roles and clinical significance of hedgehog signaling.

Authors:  Andrew P McMahon; Philip W Ingham; Clifford J Tabin
Journal:  Curr Top Dev Biol       Date:  2003       Impact factor: 4.897

5.  Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin.

Authors:  Andrzej Slominski; Jacobo Wortsman; Leonard Kohn; Kenneth B Ain; Gopalakrishnan M Venkataraman; Alexander Pisarchik; Jae Hoon Chung; Cesidio Giuliani; Mark Thornton; George Slugocki; Desmond J Tobin
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

6.  Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened.

Authors:  James K Chen; Jussi Taipale; Michael K Cooper; Philip A Beachy
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

Review 7.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases.

Authors:  Antonio C Bianco; Domenico Salvatore; Balázs Gereben; Marla J Berry; P Reed Larsen
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

8.  Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E.

Authors:  Molly Duman-Scheel; Li Weng; Shijie Xin; Wei Du
Journal:  Nature       Date:  2002-05-16       Impact factor: 49.962

Review 9.  Gli and hedgehog in cancer: tumours, embryos and stem cells.

Authors:  Ariel Ruiz i Altaba; Pilar Sánchez; Nadia Dahmane
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

10.  Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype.

Authors:  Hong Sheng; Sara Goich; Aiqin Wang; Marina Grachtchouk; Lori Lowe; Rong Mo; Kui Lin; Frederic J de Sauvage; Hiroshi Sasaki; Chi-chung Hui; Andrzej A Dlugosz
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

View more
  68 in total

Review 1.  Reawakened interest in type III iodothyronine deiodinase in critical illness and injury.

Authors:  Stephen A Huang; Antonio C Bianco
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-01-22

2.  Deiodination and cellular proliferation: parallels between development, differentiation, tumorigenesis, and now regeneration.

Authors:  Stephen A Huang
Journal:  Endocrinology       Date:  2009-01       Impact factor: 4.736

Review 3.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

Review 4.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

5.  Type 3 deiodinase, a thyroid-hormone-inactivating enzyme, controls survival and maturation of cone photoreceptors.

Authors:  Lily Ng; Arkady Lyubarsky; Sergei S Nikonov; Michelle Ma; Maya Srinivas; Benjamin Kefas; Donald L St Germain; Arturo Hernandez; Edward N Pugh; Douglas Forrest
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

Review 6.  Minireview: cracking the metabolic code for thyroid hormone signaling.

Authors:  Antonio C Bianco
Journal:  Endocrinology       Date:  2011-06-28       Impact factor: 4.736

Review 7.  Selenoproteins: molecular pathways and physiological roles.

Authors:  Vyacheslav M Labunskyy; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

Review 8.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

9.  Analysis of thyroid response element activity during retinal development.

Authors:  Nathan A Billings; Mark M Emerson; Constance L Cepko
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

Review 10.  Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem?

Authors:  Christine J Pol; Alice Muller; Warner S Simonides
Journal:  Heart Fail Rev       Date:  2010-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.